News

Histocompatibility and Immunogenetics (H&I) has traditionally focused on HLA as the major polymorphic antigen to which alloantibodies can effect a negative outcome, whether it be graft loss in transplantation or an adverse [...]

Advanced technology from Asuragen enables labs to reliably monitor leukaemia patients’ response to TKI therapy by reporting data on the international scale, ensuring effective CML treatment Chronic Myeloid Leukaemia (CML) affects 1.2 [...]

Polymerase chain reaction (PCR) is a technique used widely in molecular biology applications as a method capable of amplifying a single DNA molecule to generate millions of copies of a specific target [...]

Nucleic acid extraction is a critical part of molecular biology and is routinely used in many areas of biological and medical science. Its basis – the universal principle of all nucleic extraction [...]

Kirsty Boden has recently joined VH Bio as a Molecular Biology Technical Sales Specialist covering the South UK territory. She recently completed her PhD in Alzheimer’s research at the University of Nottingham [...]

VH Bio's HLA Technical Specialist, Ben Adams, describes the benefits and clinical utility of FLOWDSA-XM™ - a Flow Cytometry based crossmatch assay optimised for the detection of leukocyte antibodies.   Solid organ transplantation has [...]

The use of cell lines as compared to primarily cells is one that the scientific community often debates due to the many complicated factors that must be taken into account in order [...]

Ben Adams has joined VH Bio as our new HLA technical specialist. He joins the company with an outstanding background in histocompatibility and immunogenetics and having worked closely with VH Bio in [...]